( MENAFN - GlobeNewsWire - Nasdaq) Joseph M. Still Burn Center at Doctors Hospital of Augusta first to treat a patient using AVITA Medical's FDA-Approved RECELL GO System for thermal burn wounds and full-thickness skin defects VALENCIA, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc.
(NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that the Joseph M. Still Burn Center at Doctors Hospital of Augusta is the first U.S.
burn center to treat a patient using its RECELL GOTM System. Recently FDA-approved , RECELL GO is a next-generation autologous cell harvesting device that harnesses the regenerative properties of a patient's own skin to treat thermal burn wounds and full-thickness skin defects. “Completing the first case with RECELL GO at the Joseph M.
Still Burn Center is a defining moment for AVITA Medical,” said Jim Corbett, Chief Executive Officer of AVITA Medical.“Following FDA approval, our swift product deployment ensured prompt delivery to the center. The center embraced our initiative, and together with our team, their clinicians successfully completed the first case last Friday, with additional cases completed over the past three days.
With the integration of RECELL GO, we believe their clinicians will be empowered to expand treatment capabilities, reaching more patients and achieving optimal outcomes, thus setting a new standard.
